264 related articles for article (PubMed ID: 32028062)
1. Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies.
Hassan NW; Saudi MN; Abdel-Ghany YS; Ismail A; Elzahhar PA; Sriram D; Nassra R; Abdel-Aziz MM; El-Hawash SA
Bioorg Chem; 2020 Mar; 96():103610. PubMed ID: 32028062
[TBL] [Abstract][Full Text] [Related]
2. 2-Aminoaryl-3,5-diaryl pyrazines: Synthesis, biological evaluation against Mycobacterium tuberculosis and docking studies.
Gangarapu NR; Ranganatham A; Reddy EK; Yellappa S; Chandrasekhar KB
Arch Pharm (Weinheim); 2020 Jul; 353(7):e1900368. PubMed ID: 32399980
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids.
Semelková L; Janošcová P; Fernandes C; Bouz G; Janďourek O; Konečná K; Paterová P; Navrátilová L; Kuneš J; Doležal M; Zitko J
Molecules; 2017 Sep; 22(9):. PubMed ID: 28880230
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
Kumar G; Krishna VS; Sriram D; Jachak SM
Eur J Med Chem; 2018 Aug; 156():871-884. PubMed ID: 30056283
[TBL] [Abstract][Full Text] [Related]
7. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
[TBL] [Abstract][Full Text] [Related]
10. Identification and synthesis of novel inhibitors of mycobacterium ATP synthase.
Surase YB; Samby K; Amale SR; Sood R; Purnapatre KP; Pareek PK; Das B; Nanda K; Kumar S; Verma AK
Bioorg Med Chem Lett; 2017 Aug; 27(15):3454-3459. PubMed ID: 28587823
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
Jadhavar PS; Dhameliya TM; Vaja MD; Kumar D; Sridevi JP; Yogeeswari P; Sriram D; Chakraborti AK
Bioorg Med Chem Lett; 2016 Jun; 26(11):2663-9. PubMed ID: 27095514
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, In silico and In vitro Analysis of Hydrazones as Potential Antituberculosis Agents.
Thorat BR; Mali SN; Rani D; Yamgar RS
Curr Comput Aided Drug Des; 2021; 17(2):294-306. PubMed ID: 32141422
[TBL] [Abstract][Full Text] [Related]
13. Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors.
Bouz G; Juhás M; Niklová P; Janďourek O; Paterová P; Janoušek J; Tůmová L; Kovalíková Z; Kastner P; Doležal M; Zitko J
Molecules; 2017 Oct; 22(10):. PubMed ID: 29065539
[TBL] [Abstract][Full Text] [Related]
14. Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates.
Ribeiro RCB; de Marins DB; Di Leo I; da Silva Gomes L; de Moraes MG; Abbadi BL; Villela AD; da Silva WF; da Silva LCRP; Machado P; Bizarro CV; Basso LA; Cristina de Moraes M; Ferreira VF; da Silva FC; Nascimento V
Eur J Med Chem; 2021 Jan; 209():112859. PubMed ID: 33010635
[TBL] [Abstract][Full Text] [Related]
15. Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies.
Pisal MM; Nawale LU; Patil MD; Bhansali SG; Gajbhiye JM; Sarkar D; Chavan SP; Borate HB
Eur J Med Chem; 2017 Feb; 127():459-469. PubMed ID: 28103537
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis.
Chitre TS; Asgaonkar KD; Miniyar PB; Dharme AB; Arkile MA; Yeware A; Sarkar D; Khedkar VM; Jha PC
Bioorg Med Chem Lett; 2016 May; 26(9):2224-8. PubMed ID: 27017114
[TBL] [Abstract][Full Text] [Related]
17. One-pot synthesis, spectral characterization, biological evaluation, molecular docking studies and in silico ADME/Tox profiling of new 2,4,5 triaryl imidazole derivatives as anti tubercular agents.
Munnaluri RK; Chevula J; Patnam N; Yamini L; Manga V
Indian J Tuberc; 2023 Oct; 70(4):451-459. PubMed ID: 37968051
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK
Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456
[TBL] [Abstract][Full Text] [Related]
19.
Deb PK; Al-Shar'i NA; Venugopala KN; Pillay M; Borah P
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):869-884. PubMed ID: 34060396
[TBL] [Abstract][Full Text] [Related]
20. 5-Alkylamino-
Ambrożkiewicz W; Kučerová-Chlupáčová M; Janďourek O; Konečná K; Paterová P; Bárta P; Vinšová J; Doležal M; Zitko J
Molecules; 2020 Mar; 25(7):. PubMed ID: 32231166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]